Helicobacter pylori -associated immune thrombocytopenia: Clinical features and pathogenic mechanisms

World Journal of Gastroenterology

Volumn 20, Issue 3, 2014, Pages 714-723

  Kuwana, Masataka ^a  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Autoantibody; Childhood; Fc receptor; Helicobacter pylori; Idiopathic thrombocytopenic purpura; Immune thrombocytopenia; Systemic lupus erythematosus

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLARITHROMYCIN PLUS LANSOPRAZOLE; CAGA PROTEIN; CLARITHROMYCIN; DEXAMETHASONE; EPITHELIAL DERIVED NEUTROPHIL ACTIVATING FACTOR 78; FC RECEPTOR; FC RECEPTOR IIB; GLYCOPROTEIN; HLA DQB1 ANTIGEN; HLA DRB1 ANTIGEN; IMMUNOGLOBULIN; IMMUNOGLOBULIN G ANTIBODY; INTERLEUKIN 1BETA; LYMPHOTOXIN; METRONIDAZOLE; MONOCYTE CHEMOTACTIC PROTEIN 1; THROMBOCYTE ANTIBODY; TOLL LIKE RECEPTOR; VON WILLEBRAND FACTOR;

ANTIBODY RESPONSE; ARTICLE; AUTOIMMUNE THROMBOCYTOPENIA; CHILDHOOD DISEASE; CROSS REACTION; DISEASE ASSOCIATION; DRUG MEGADOSE; ERADICATION THERAPY; GENETIC POLYMORPHISM; HELICOBACTER INFECTION; HUMAN; IMMUNE RESPONSE; INFLAMMATION; MACROPHAGE FUNCTION; META ANALYSIS (TOPIC); MULTICENTER STUDY (TOPIC); PATHOGENESIS; PREVALENCE; REMISSION; SCREENING; STOMACH ATROPHY; SYSTEMATIC REVIEW (TOPIC); THROMBOCYTE COUNT; TREATMENT RESPONSE;

AUTOANTIBODY; CHILDHOOD; FCΓ RECEPTOR; HELICOBACTER PYLORI; IDIOPATHIC THROMBOCYTOPENIC PURPURA; IMMUNE THROMBOCYTOPENIA; SYSTEMIC LUPUS ERYTHEMATOSUS;

ANIMALS; ANTI-BACTERIAL AGENTS; ANTIGENS, BACTERIAL; AUTOANTIBODIES; AUTOIMMUNITY; BLOOD PLATELETS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; PROTON PUMP INHIBITORS; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC; RISK FACTORS; TREATMENT OUTCOME;

EID: 84892896906     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v20.i3.714     Document Type: Article

References (73)

1. Tan HJ, Goh KL. Extragastrointestinal manifestations of Helicobacter pylori infection: facts or myth? A critical review. J Dig Dis 2012; 13: 342-349 [PMID: 22713083 DOI: 10.1111/ j.1751-2980.2012.00599.x]
2. Stasi R. Immune thrombocytopenia: pathophysiologic and clinical update. Semin Thromb Hemost 2012; 38: 454-462 [PMID: 22753097 DOI: 10.1055/s-0032-1305780]
3. Stasi R, Willis F, Shannon MS, Gordon-Smith EC. Infectious causes of chronic immune thrombocytopenia. Hematol Oncol Clin North Am 2009; 23: 1275-1297 [PMID: 19932434 DOI: 10.1016/j.hoc.2009.08.009]
4. Gasbarrini A, Franceschi F, Tartaglione R, Landolfi R, Pola P, Gasbarrini G. Regression of autoimmune thrombocytopenia after eradication of Helicobacter pylori. Lancet 1998; 352: 878 [PMID: 9742983]
5. Neunert C, Lim W, Crowther M, Cohen A, Solberg L, Crowther MA. The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia. Blood 2011; 117: 4190-4207 [PMID: 21325604 DOI: 10.1182/blood-2010-08-302984]
6. Kuwana M, Ikeda Y. Helicobacter pylori and immune thrombocytopenic purpura: unsolved questions and controversies. Int J Hematol 2006; 84: 309-315 [PMID: 17118756]
7. Franchini M, Veneri D. Helicobacter pylori-associated immune thrombocytopenia. Platelets 2006; 17: 71-77 [PMID: 16421007]
8. Stasi R, Provan D. Helicobacter pylori and Chronic ITP. Hematology Am Soc Hematol Educ Program 2008: 206-211 [PMID: 19074084 DOI: 10.1182/asheducation-2008.1.206]
9. Fujimura K, Kuwana M, Kurata Y, Imamura M, Harada H, Sakamaki H, Teramura M, Koda K, Nomura S, Sugihara S, Shimomura T, Fujimoto TT, Oyashiki K, Ikeda Y. Is eradication therapy useful as the first line of treatment in Helicobacter pylori-positive idiopathic thrombocytopenic purpura? Analysis of 207 eradicated chronic ITP cases in Japan. Int J Hematol 2005; 81: 162-168 [PMID: 15765787]
10. Soldinger E, Pilia MC, Piubello W, Nadali G. Multi-resistant idiopathic thrombocytopenia successfully treated by eradication of Helicobacter pylori. Dig Liver Dis 2001; 33: 732 [PMID: 11785722]
11. Rinaldi CR, Camera A, Viscardi G, Pane F, Rotoli B. Complete remission in a case of severe multi-resistant idiopathic thrombocytopenic purpura after Helicobacter pylori eradication. Am J Hematol 2008; 83: 683-684 [PMID: 18508319 DOI: 10.1002/ajh.21200]
12. Asahi A, Kuwana M, Suzuki H, Hibi T, Kawakami Y, Ikeda Y. Effects of a Helicobacter pylori eradication regimen on antiplatelet autoantibody response in infected and uninfected patients with idiopathic thrombocytopenic purpura. Haematologica 2006; 91: 1436-1437 [PMID: 16963398]
13. Tsumoto C, Tominaga K, Okazaki H, Tanigawa T, Yamagami H, Watanabe K, Nakao T, Koh K, Watanabe T, Fujiwara Y, Yamane T, Oshitani N, Hino M, Higuchi K, Arakawa T. Long-term efficacy of Helicobacter pylori eradication in patients with idiopathic thrombocytopenic purpura: 7-year follow-up prospective study. Ann Hematol 2009; 88: 789-793 [PMID: 19096845 DOI: 10.1007/s00277-008-0667-5]
14. Kikuchi T, Kobayashi T, Yamashita T, Ohashi K, Sakamaki H, Akiyama H. Eight-year follow-up of patients with immune thrombocytopenic purpura related toH. pyloriinfection. Platelets 2011; 22: 61-64 [PMID: 20942598 DOI: 10.3109/ 09537104.2010.515272]
15. Franchini M, Cruciani M, Mengoli C, Pizzolo G, Veneri D. Effect of Helicobacter pylori eradication on platelet count in idiopathic thrombocytopenic purpura: a systematic review and meta-analysis. J Antimicrob Chemother 2007; 60: 237-246 [PMID: 17561502]
16. Stasi R, Sarpatwari A, Segal JB, Osborn J, Evangelista ML, Cooper N, Provan D, Newland A, Amadori S, Bussel JB. Effects of eradication of Helicobacter pylori infection in patients with immune thrombocytopenic purpura: a systematic review. Blood 2009; 113: 1231-1240 [PMID: 18945961 DOI: 10.1182/blood-2008-07-167155]
17. Arnold DM, Bernotas A, Nazi I, Stasi R, Kuwana M, Liu Y, Kelton JG, Crowther MA. Platelet count response to H. pylori treatment in patients with immune thrombocytopenic purpura with and without H. pylori infection: a systematic review. Haematologica 2009; 94: 850-856 [PMID: 19483158 DOI: 10.3324/haematol.2008.005348]
18. Fujimura K. Helicobacter pylori infection and idiopathic thrombocytopenic purpura. Int J Hematol 2005; 81: 113-118 [PMID: 15765778]
19. Franchini M, Vescovi PP, Garofano M, Veneri D. Helicobacter pylori-associated idiopathic thrombocytopenic purpura: a narrative review. Semin Thromb Hemost 2012; 38: 463-468 [PMID: 22753098 DOI: 10.1055/s-0032-1305781]
20. Jarque I, Andreu R, Llopis I, De la Rubia J, Gomis F, Senent L, Jiménez C, Martín G, Martínez JA, Sanz GF, Ponce J, Sanz MA. Absence of platelet response after eradication of Helicobacter pylori infection in patients with chronic idiopathic thrombocytopenic purpura. Br J Haematol 2001; 115: 1002-1003 [PMID: 11843840]
21. Ahn ER, Tiede MP, Jy W, Bidot CJ, Fontana V, Ahn YS. Platelet activation in Helicobacter pylori-associated idiopathic thrombocytopenic purpura: eradication reduces platelet activation but seldom improves platelet counts. Acta Haematol 2006; 116: 19-24 [PMID: 16809885]
22. Michel M, Khellaf M, Desforges L, Lee K, Schaeffer A, Godeau B, Bierling P. Autoimmune thrombocytopenic Purpura and Helicobacter pylori infection. Arch Intern Med 2002; 162: 1033-1036 [PMID: 11996614]
23. Fujimura K, Miyakawa Y, Kurata Y, Kuwana M, Tomiyama Y, Murata M. Reference guide for management of adult idiopathic thrombocytopenic purpura (ITP) 2012 version. Rinsho Ketsueki 2012; 53: 433-442 [PMID: 22687977]
24. Provan D, Stasi R, Newland AC, Blanchette VS, Bolton-Maggs P, Bussel JB, Chong BH, Cines DB, Gernsheimer TB, Godeau B, Grainger J, Greer I, Hunt BJ, Imbach PA, Lyons G, McMillan R, Rodeghiero F, Sanz MA, Tarantino M, Watson S, Young J, Kuter DJ. International consensus report on the investigation and management of primary immune thrombocytopenia. Blood 2010; 115: 168-186 [PMID: 19846889 DOI: 10.1182/blood-2009-06-225565]
25. Takahashi T, Yujiri T, Shinohara K, Inoue Y, Sato Y, Fujii Y, Okubo M, Zaitsu Y, Ariyoshi K, Nakamura Y, Nawata R, Oka Y, Shirai M, Tanizawa Y. Molecular mimicry by Helicobacter pylori CagA protein may be involved in the pathogenesis of H. pylori-associated chronic idiopathic thrombocytopenic purpura. Br J Haematol 2004; 124: 91-96 [PMID: 14675413]
26. Franceschi F, Christodoulides N, Kroll MH, Genta RM. Helicobacter pylori and idiopathic thrombocytopenic purpura. Ann Intern Med 2004; 140: 766-767 [PMID: 15126268]
27. Suzuki R, Shiota S, Yamaoka Y. Molecular epidemiology, population genetics, and pathogenic role of Helicobacter pylori. Infect Genet Evol 2012; 12: 203-213 [PMID: 22197766 DOI: 10.1016/j.meegid.2011.12.002]
28. De Mattia D, Del Vecchio GC, Russo G, De Santis A, Ramenghi U, Notarangelo L, Jankovic M, Molinari AC, Zecca M, Nobili B, Giordano P. Management of chronic childhood immune thrombocytopenic purpura: AIEOP consensus guidelines. Acta Haematol 2010; 123: 96-109 [PMID: 20029174 DOI: 10.1159/000268855]
29. Rajantie J, Klemola T. Helicobacter pylori and idiopathic thrombocytopenic purpura in children. Blood 2003; 101: 1660 [PMID: 12560248]
30. Jaing TH, Yang CP, Hung IJ, Chiu CH, Chang KW. Efficacy of Helicobacter pylori eradication on platelet recovery in children with chronic idiopathic thrombocytopenic purpura. Acta Paediatr 2003; 92: 1153-1157 [PMID: 14632330]
31. Hayashi H, Okuda M, Aoyagi N, Yoshiyama M, Miyashiro E, Kounami S, Yoshikawa N. Helicobacter pylori infection in children with chronic idiopathic thrombocytopenic purpura. Pediatr Int 2005; 47: 292-295 [PMID: 15910453]
32. Yetgin S, Demir H, Arslan D, Unal S, Koçak N. Autoimmune thrombocytopenic purpura and Helicobacter pylori infection effectivity during childhood. Am J Hematol 2005; 78: 318 [PMID: 15795919]
33. Jaing TH, Tsay PK, Hung IJ, Chiu CH, Yang CP, Huang IA. The role of Helicobacter pylori infection in children with acute immune thrombocytopenic purpura. Pediatr Blood Cancer 2006; 47: 215-217 [PMID: 16261593]
34. Loffredo G, Marzano MG, Migliorati R, Miele E, Menna F, Poggi V, Staiano A. The relationship between immune thrombocytopenic purpura and Helicobacter pylori infection in children: where is the truth? Eur J Pediatr 2007; 166: 1067-1068 [PMID: 17136353]
35. Neefjes VM, Heijboer H, Tamminga RY. H. pylori infection in childhood chronic immune thrombocytopenic purpura. Haematologica 2007; 92: 576 [PMID: 17488677]
36. Wu KS, Hsiao CC, Yu HR, Huang EY, Mai WL, Sheen JM. Helicobacter pylori infection and childhood idiopathic thrombocytopenic purpura. Acta Paediatr Taiwan 2007; 48: 263-266 [PMID: 18254575]
37. Bisogno G, Errigo G, Rossetti F, Sainati L, Pusiol A, Da Dalt L, Colleselli P, Grotto P, Carli M. The role of Helicobacter pylori in children with chronic idiopathic thrombocytopenic purpura. J Pediatr Hematol Oncol 2008; 30: 53-57 [PMID: 18176181 DOI: 10.1097/MPH.0b013e3181615613]
38. Hamidieh AA, Arzanian MT, Gachkar L, Pasha F. Helicobacter pylori infection in children with chronic idiopathic thrombocytopenic purpura. J Pediatr Hematol Oncol 2008; 30: 96-97 [PMID: 18176194 DOI: 10.1097/ MPH.0b013e3181615600]
39. Treepongkaruna S, Sirachainan N, Kanjanapongkul S, Winaichatsak A, Sirithorn S, Sumritsopak R, Chuansumrit A. Absence of platelet recovery following Helicobacter pylori eradication in childhood chronic idiopathic thrombocytopenic purpura: a multi-center randomized controlled trial. Pediatr Blood Cancer 2009; 53: 72-77 [PMID: 19301380]
40. Ferrara M, Capozzi L, Russo R. Effect of Helicobacter pylori eradication on platelet count in children with chronic idiopathic thrombocytopenic purpura. Hematology 2009; 14: 282-285 [PMID: 19843384 DOI: 10.1179/102453309X12473408 860181]
41. Maghbool M, Maghbool M, Shahriari M, Karimi M. Does Helicobacter pylori play a role in the pathogenesis of childhood chronic idiopathic thrombocytopenic purpura? Pediatr Rep 2009; 1: e2 [PMID: 21589818 DOI: 10.4081/pr.2009.e2]
42. Russo G, Miraglia V, Branciforte F, Matarese SM, Zecca M, Bisogno G, Parodi E, Amendola G, Giordano P, Jankovic M, Corti A, Nardi M, Farruggia P, Battisti L, Baronci C, Palazzi G, Tucci F, Ceppi S, Nobili B, Ramenghi U, De Mattia D, Notarangelo L. Effect of eradication of Helicobacter pylori in children with chronic immune thrombocytopenia: a prospective, controlled, multicenter study. Pediatr Blood Cancer 2011; 56: 273-278 [PMID: 20830773 DOI: 10.1002/pbc.22770]
43. Cines DB, Liebman H, Stasi R. Pathobiology of secondary immune thrombocytopenia. Semin Hematol 2009; 46: S2-S14 [PMID: 19245930 DOI: 10.1053/j.seminhematol.2008.12.005]
44. Suerbaum S, Michetti P. Helicobacter pylori infection. N Engl J Med 2002; 347: 1175-1186 [PMID: 12374879]
45. Veneri D, De Matteis G, Solero P, Federici F, Zanuso C, Guizzardi E, Arena S, Gaio M, Pontiero P, Ricetti MM, Franchini M. Analysis of B-and T-cell clonality and HLA class II alleles in patients with idiopathic thrombocytopenic purpura: correlation with Helicobacter pylori infection and response to eradication treatment. Platelets 2005; 16: 307-311 [PMID: 16011982]
46. Satoh T, Pandey JP, Okazaki Y, Asahi A, Kawakami Y, Ikeda Y, Kuwana M. Single nucleotide polymorphism of interleukin-1beta associated with Helicobacter pylori infection in immune thrombocytopenic purpura. Tissue Antigens 2009; 73: 353-357 [PMID: 19317746 DOI: 10.1111/ j.1399-0039.2009.01214.x]
47. Hashino S, Mori A, Suzuki S, Izumiyama K, Kahata K, Yonezumi M, Chiba K, Kondo T, Ota S, Toyashima N, Kato N, Tanaka J, Imamura M, Asaka M. Platelet recovery in patients with idiopathic thrombocytopenic purpura after eradication of Helicobacter pylori. Int J Hematol 2003; 77: 188-191 [PMID: 12627857]
48. Nomura S, Inami N, Kanazawa S. The effects of Helicobacter pylori eradication on chemokine production in patients with immune thrombocytopenic purpura. Eur J Haematol 2004; 72: 304-305 [PMID: 15089773]
49. Stasi R, Rossi Z, Stipa E, Amadori S, Newland AC, Provan D. Helicobacter pylori eradication in the management of patients with idiopathic thrombocytopenic purpura. Am J Med 2005; 118: 414-419 [PMID: 15808140]
50. Kodama M, Kitadai Y, Ito M, Kai H, Masuda H, Tanaka S, Yoshihara M, Fujimura K, Chayama K. Immune response to CagA protein is associated with improved platelet count after Helicobacter pylori eradication in patients with idiopathic thrombocytopenic purpura. Helicobacter 2007; 12: 36-42 [PMID: 17241299]
51. Ando K, Shimamoto T, Tauchi T, Ito Y, Kuriyama Y, Gotoh A, Miyazawa K, Kimura Y, Kawai T, Ohyashiki K. Can eradication therapy for Helicobacter pylori really improve the thrombocytopenia in idiopathic thrombocytopenic purpura? Our experience and a literature review. Int J Hematol 2003; 77: 239-244 [PMID: 12731666]
52. Inaba T, Mizuno M, Take S, Suwaki K, Honda T, Kawai K, Fujita M, Tamura T, Yokota K, Oguma K, Okada H, Shiratori Y. Eradication of Helicobacter pylori increases platelet count in patients with idiopathic thrombocytopenic purpura in Japan. Eur J Clin Invest 2005; 35: 214-219 [PMID: 15733077]
53. Emilia G, Luppi M, Zucchini P, Morselli M, Potenza L, Forghieri F, Volzone F, Jovic G, Leonardi G, Donelli A, Torelli G. Helicobacter pylori infection and chronic immune thrombocytopenic purpura: long-term results of bacterium eradication and association with bacterium virulence profiles. Blood 2007; 110: 3833-3841 [PMID: 17652264]
54. Sato R, Murakami K, Watanabe K, Okimoto T, Miyajima H, Ogata M, Ohtsuka E, Kodama M, Saburi Y, Fujioka T, Nasu M. Effect of Helicobacter pylori eradication on platelet recovery in patients with chronic idiopathic thrombocytopenic purpura. Arch Intern Med 2004; 164: 1904-1907 [PMID: 15451766]
55. Suzuki T, Matsushima M, Shirakura K, Koike J, Masui A, Takagi A, Shirasugi Y, Ogawa Y, Shirai T, Mine T. Association of inflammatory cytokine gene polymorphisms with platelet recovery in idiopathic thrombocytopenic purpura patients after the eradication of Helicobacter pylori. Digestion 2008; 77: 73-78 [PMID: 18354254 DOI: 10.1159/000121392]
56. Satoh T, Miyazaki K, Shimohira A, Amano N, Okazaki Y, Nishimoto T, Akahoshi T, Munekata S, Kanoh Y, Ikeda Y, Higashihara M, Takahashi S, Kuwana M. Fcγ receptor IIB gene polymorphism in adult Japanese patients with primary immune thrombocytopenia. Blood 2013; 122: 1991-1992 [PMID: 24030263 DOI: 10.1182/blood-2013-05-501858]
57. Scandellari R, Allemand E, Vettore S, Plebani M, Randi ML, Fabris F. Platelet response to Helicobacter pylori eradication therapy in adult chronic idiopathic thrombocytopenic purpura seems to be related to the presence of anticytotoxin-associated gene A antibodies. Blood Coagul Fibrinolysis 2009; 20: 108-113 [PMID: 19786938 DOI: 10.1097/ MBC.0b013e32832315d8]
58. Sato R, Murakami K, Okimoto T, Watanabe K, Kodama M, Fujioka T. Development of corpus atrophic gastritis may be associated with Helicobacter pylori-related idiopathic thrombocytopenic purpura. J Gastroenterol 2011; 46: 991-997 [PMID: 21594563 DOI: 10.1007/s00535-011-0416-8]
59. Matsukawa Y, Iwamoto M, Kato K, Mizuno S, Gon Y, Hemmi A, Shirinskaya N, Takeuchi J, Sawada S. Long term changes in platelet counts after H. pylori eradication in non-ITP patients. Platelets 2010; 21: 628-631 [PMID: 20849211 DOI: 10.3109/09537104.2010.510894]
60. Bai Y, Wang Z, Bai X, Yu Z, Cao L, Zhang W, Ruan C. Crossreaction of antibody against Helicobacter pylori urease B with platelet glycoprotein IIIa and its significance in the pathogenesis of immune thrombocytopenic purpura. Int J Hematol 2009; 89: 142-149 [PMID: 19184277 DOI: 10.1007/ s12185-008-0247-4]
61. Yamanishi S, Iizumi T, Watanabe E, Shimizu M, Kamiya S, Nagata K, Kumagai Y, Fukunaga Y, Takahashi H. Implications for induction of autoimmunity via activation of B-1 cells by Helicobacter pylori urease. Infect Immun 2006; 74: 248-256 [PMID: 16368978]
62. Pellicano R, Touscoz GA, Smedile A, Berrutti M, Saracco G, Repici A, Ponzetto A, Rizzetto M. Prevalence of non-organspecific autoantibodies in patients suffering from duodenal ulcer with and without Helicobacter pylori infection. Dig Dis Sci 2004; 49: 395-398 [PMID: 15139486]
63. Kuwana M, Kaburaki J, Ikeda Y. Autoreactive T cells to platelet GPIIb-IIIa in immune thrombocytopenic purpura. Role in production of anti-platelet autoantibody. J Clin Invest 1998; 102: 1393-1402 [PMID: 9769332]
64. Kuwana M, Ikeda Y. The role of autoreactive T-cells in the pathogenesis of idiopathic thrombocytopenic purpura. Int J Hematol 2005; 81: 106-112 [PMID: 15765777]
65. Nishimoto T, Kuwana M. CD4+CD25+Foxp3+ regulatory T cells in the pathophysiology of immune thrombocytopenia. Semin Hematol 2013; 50 Suppl 1: S43-S49 [PMID: 23664516 DOI: 10.1053/j.seminhematol.2013.03.018]
66. Kuwana M, Okazaki Y, Ikeda Y. Splenic macrophages maintain the anti-platelet autoimmune response via uptake of opsonized platelets in patients with immune thrombocytopenic purpura. J Thromb Haemost 2009; 7: 322-329 [PMID: 18826388 DOI: 10.1111/j.1538-7836.2008.03161.x]
67. Asahi A, Nishimoto T, Okazaki Y, Suzuki H, Masaoka T, Kawakami Y, Ikeda Y, Kuwana M. Helicobacter pylori eradication shifts monocyte Fcgamma receptor balance toward inhibitory FcgammaRIIB in immune thrombocytopenic purpura patients. J Clin Invest 2008; 118: 2939-2949 [PMID: 18654664 DOI: 10.1172/JCI34496]
68. Wu Z, Zhou J, Prsoon P, Wei X, Liu X, Peng B. Low expression of FCGRIIB in macrophages of immune thrombocytopenia-affected individuals. Int J Hematol 2012; 96: 588-593 [PMID: 23054650 DOI: 10.1007/s12185-012-1187-6]
69. Suzuki H, Mori M, Seto K, Kai A, Kawaguchi C, Suzuki M, Suematsu M, Yoneta T, Miura S, Ishii H. Helicobacter pyloriassociated gastric pro-and antioxidant formation in Mongolian gerbils. Free Radic Biol Med 1999; 26: 679-684 [PMID: 10218657]
70. Ferrero RL. Innate immune recognition of the extracellular mucosal pathogen, Helicobacter pylori. Mol Immunol 2005; 42: 879-885 [PMID: 15829277]
71. Samuelsson A, Towers TL, Ravetch JV. Anti-inflammatory activity of IVIG mediated through the inhibitory Fc receptor. Science 2001; 291: 484-486 [PMID: 11161202]
72. Liu XG, Ma SH, Sun JZ, Ren J, Shi Y, Sun L, Dong XY, Qin P, Guo CS, Hou M, Peng J. High-dose dexamethasone shifts the balance of stimulatory and inhibitory Fcgamma receptors on monocytes in patients with primary immune thrombocytopenia. Blood 2011; 117: 2061-2069 [PMID: 21131591 DOI: 10.1182/blood-2010-07-295477]
73. Byrne MF, Kerrigan SW, Corcoran PA, Atherton JC, Murray FE, Fitzgerald DJ, Cox DM. Helicobacter pylori binds von Willebrand factor and interacts with GPIb to induce platelet aggregation. Gastroenterology 2003; 124: 1846-1854 [PMID: 12806618]